Use of epigallocatechin-3-gallate for immune regulation
    3.
    发明申请
    Use of epigallocatechin-3-gallate for immune regulation 审中-公开
    表没食子儿茶素-3-没食子酸酯用于免疫调节

    公开(公告)号:US20120309821A1

    公开(公告)日:2012-12-06

    申请号:US13153088

    申请日:2011-06-03

    CPC分类号: A61K31/353

    摘要: The preset invention relates to a method for treating lupus erythematosus, particularly lupus nephritis, comprising administering a subject in need thereof a therapeutically effective amount of epigallocatechin-3-gallate (EGCG) or a pharmaceutically acceptable salt or a physiologically functional derivative, together with one or more pharmaceutically acceptable carriers, diluents or excipients.

    摘要翻译: 本发明涉及一种治疗红斑狼疮,特别是狼疮肾炎的方法,其包括给予有需要的受试者治疗有效量的表没食子儿茶素-3-没食子酸酯(EGCG)或其药学上可接受的盐或生理功能衍生物,以及一种 或更多的药学上可接受的载体,稀释剂或赋形剂。

    Treatment for nephritis
    4.
    发明授权
    Treatment for nephritis 有权
    治疗肾炎

    公开(公告)号:US09295705B2

    公开(公告)日:2016-03-29

    申请号:US13290519

    申请日:2011-11-07

    摘要: This invention relates to methods for treatment of nephritis. This invention further provides a method of treating with nephritis comprising administering to the subject an amount of herbal pharmaceutical composition thereof effective to treat the subject. Move particularly, this invention provides an herbal pharmaceutical composition comprising Rhizoma Atractylodis macrocephalae, Eucommiae cortex, Lonicerae caulis, and Hedyotidis diffusae Herba thereof for use in treating a subject afflicted with active nephritis.

    摘要翻译: 本发明涉及治疗肾炎的方法。 本发明进一步提供了一种治疗肾炎的方法,包括向受试者施用有效治疗受试者的量的草药组合物。 特别地,本发明提供了一种草药药物组合物,其包含白术大戟科,杜仲皮,金银花,以及禾本科植物禾本科植物,用于治疗患有活动性肾炎的受试者。

    METHOD FOR DIAGNOSING KIDNEY DISEASE COMPRISING DETECTING THE LEVEL OF ANNEXIN A2 OR S100A6
    7.
    发明申请
    METHOD FOR DIAGNOSING KIDNEY DISEASE COMPRISING DETECTING THE LEVEL OF ANNEXIN A2 OR S100A6 审中-公开
    检测包含ANNEXIN A2或S100A6水平的KIDNEY病的方法

    公开(公告)号:US20130101998A1

    公开(公告)日:2013-04-25

    申请号:US13618657

    申请日:2012-09-14

    IPC分类号: G01N33/68

    CPC分类号: G01N33/6893 G01N2800/347

    摘要: The present invention provides biomarkers for detecting kidney disease, selected from the oligonucleotide sequence, complementary sequence or derivatives, amino acid sequence or derivatives, fragment, variants, antibody of annexin A2 or S100A6 or combinations thereof. Moreover, the present invention also provides an assay kit and a method for kidney disease detecting, practically for the kidney disease resulting from acute tubular necrosis.

    摘要翻译: 本发明提供了用于检测肾病的生物标志物,其选自寡核苷酸序列,互补序列或衍生物,氨基酸序列或衍生物,片段,变体,膜联蛋白A2或S100A6的抗体或其组合。 此外,本发明还提供了用于肾脏疾病检测的测定试剂盒和方法,实际上用于由急性肾小管坏死引起的肾脏疾病。

    Method for diagnosing kidney disease comprising detecting the level of annexin A2
    9.
    发明授权
    Method for diagnosing kidney disease comprising detecting the level of annexin A2 有权
    用于诊断肾脏疾病的方法,包括检测膜联蛋白A2的水平

    公开(公告)号:US08329410B2

    公开(公告)日:2012-12-11

    申请号:US12540146

    申请日:2009-08-12

    IPC分类号: G01N33/53 C12Q1/68 C07K14/47

    CPC分类号: G01N33/6893 G01N2800/347

    摘要: The present invention provides biomarkers for detecting kidney disease, selected from the oligonucleotide sequence, complementary sequence or derivatives, amino acid sequence or derivatives, fragment, variants, antibody of annexin A2 or S100A6 or combinations thereof. Moreover, the present invention also provides an assay kit and a method for kidney disease detecting, practically for the kidney disease resulting from acute tubular necrosis.

    摘要翻译: 本发明提供了用于检测肾病的生物标志物,其选自寡核苷酸序列,互补序列或衍生物,氨基酸序列或衍生物,片段,变体,膜联蛋白A2或S100A6的抗体或其组合。 此外,本发明还提供了用于肾脏疾病检测的测定试剂盒和方法,实际上用于由急性肾小管坏死引起的肾脏疾病。

    Serpine2 as a biomarker for IgA nephropathy
    10.
    发明授权
    Serpine2 as a biomarker for IgA nephropathy 有权
    Serpine2作为IgA肾病的生物标志物

    公开(公告)号:US08178358B2

    公开(公告)日:2012-05-15

    申请号:US12695907

    申请日:2010-01-28

    申请人: Ann Chen Shuk-Man Ka

    发明人: Ann Chen Shuk-Man Ka

    摘要: The present invention provides a method for diagnosis or prognosis of IgA nephropathy in a subject based on detection of the expression level of one or more biomarker genes selected from the group consisting of thymosin β4 (Tmsb4), serine or cysteine proteinase inhibitor clade E member 2 (Serpine2), secreted phosphoprotein 1 (OPN), butyrophilin-like-2 (BTNL2), S100 calcium binding protein A8 (S100A8), Cystatin C (CysC), and any combination thereof.

    摘要翻译: 本发明提供了一种基于检测选自胸腺素和bgr4(Tmsb4),丝氨酸或半胱氨酸蛋白酶抑制剂进化枝E的一种或多种生物标记基因的表达水平的检测对象的IgA肾病的诊断或预后的方法 成员2(Serpine2),分泌的磷蛋白1(OPN),丁酸激素-2(BTNL2),S100钙结合蛋白A8(S1​​00A8),半胱氨酸蛋白酶抑制剂C(CysC)及其任何组合。